Literature DB >> 31865557

The prognostic and diagnostic use of hematological parameters in subacute thyroiditis patients.

Murat Calapkulu1, Muhammed Erkam Sencar2, Davut Sakiz3, Hakan Duger2, Ilknur Ozturk Unsal2, Mustafa Ozbek2, Erman Cakal2.   

Abstract

BACKGROUND: Subacute thyroiditis (SAT) is an acute inflammatory disease of the thyroid. Mean platelet volume (MPV), neutrophil-to-lymphocyte ratio (NLR), and platelet-to-lymphocyte ratio (PLR) values determined from peripheral blood, are accepted as available and practical indicators of systemic inflammation. The purpose of this study was to evaluate the value of hematological parameters in the diagnosis and prognosis of subacute thyroiditis patients.
METHODS: This retrospective study included 306 SAT patients and 102 healthy control subjects. Retrospective analyses were made of age, gender, complete blood counts, C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), thyroid function tests, NLR, PLR, and thyroid volume of the patients and the results were compared with the control group.
RESULTS: The mean follow-up time of patients was 29.5 ± 14 months. The ESR, CRP, white blood cell (WBC) count, neutrophil count, hemoglobin, platelet counts, NLR, and PLR were significantly higher in the SAT patients. MPV and lymphocyte count were significantly lower in the SAT patients. The rates of recurrence and permanent hypothyroidism were 15.4% and 9.8%, respectively. The values of ESR, CRP, NLR, PLR, and MPV at the time of diagnosis were not determined to have any effect on recurrence or the development of permanent hypothyroidism.
CONCLUSIONS: The results of this study showed higher PLR and NLR values in SAT patients compared with healthy control subjects, and a lower MPV value. These findings demonstrate that the assessment of hematological parameters in conjunction with radiological and clinical findings will assist in establishing an accurate diagnosis, especially in complicated SAT cases.

Entities:  

Keywords:  Hypothyroidism; Mean platelet volume; Neutrophil-to-lymphocyte ratio; Platelet-to-lymphocyte ratio; Recurrence; Subacute thyroiditis

Mesh:

Year:  2019        PMID: 31865557     DOI: 10.1007/s12020-019-02163-w

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  6 in total

1.  Early Thyroid Volume Reduction in Subacute Thyroiditis Can be a Potential Indicator for Hypothyroidism.

Authors:  Ji Yong Park; Wonsuk Choi; A Ram Hong; Jee Hee Yoon; Hee Kyung Kim; Ho-Cheol Kang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-30       Impact factor: 6.055

2.  Combination of the neutrophil to lymphocyte ratio and serum toluidine red unheated serum test titer as a predictor of neurosyphilis in HIV-negative patients.

Authors:  Caifeng He; Xianjin Shang; Wenbei Liu; Shouyun Hang; Jingtao Chen; Chao Ci
Journal:  Exp Ther Med       Date:  2021-01-07       Impact factor: 2.447

Review 3.  New aspects in the pathogenesis and management of subacute thyroiditis.

Authors:  Magdalena Stasiak; Andrzej Lewiński
Journal:  Rev Endocr Metab Disord       Date:  2021-05-05       Impact factor: 6.514

4.  Predictive significance of neutrophil-to-lymphocyte and platelet-to-lymphocyte for cytomegalovirus infection in infants less than 3 months: A retrospective study.

Authors:  Canyang Zhan; Weiyan Wang; Lihua Chen
Journal:  J Clin Lab Anal       Date:  2021-11-22       Impact factor: 3.124

5.  The diagnostic value of blood cell-derived indexes in subacute thyroiditis patients with thyrotoxicosis: a retrospective study.

Authors:  Peichun He; Haiyan Yang; Qingsun Lai; Yaqi Kuang; Zhenxing Huang; Xinghuan Liang; Hong Huang; Yingfen Qin; Zuojie Luo
Journal:  Ann Transl Med       Date:  2022-03

6.  Clinical Significance of Erythrocyte Sedimentation Rate, Leukocyte, Fibrinogen, C-Reactive Protein, and Pentraxin 3 Values in Thyroid Nodules.

Authors:  Sabahattin Destek; Beyza Benturk; Yunus Yapalak; Omer Faruk Ozer
Journal:  Sisli Etfal Hastan Tip Bul       Date:  2022-06-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.